Fused heterocyclic M1 positive allosteric modulators.

Area of Science:

• Medicinal Chemistry
• Neuroscience
• Pharmacology

Background:

• The M1 muscarinic acetylcholine receptor (M1R) is a key target for treating cognitive disorders.
• Existing M1 positive allosteric modulators (M1 PAMs) often face challenges with central nervous system (CNS) penetration and potency.
• Structure-activity relationship (SAR) studies are crucial for optimizing drug candidates.

Purpose of the Study:

• To identify novel M1 PAMs with improved CNS penetrance and potency.
• To explore the replacement of the phenyl B-ring linkage in existing M1 PAM scaffolds.
• To guide the design of next-generation M1R modulators for neurological conditions.

Main Methods:

• Conducted a comprehensive structure-activity relationship (SAR) study.
• Synthesized and evaluated a series of novel compounds.
• Utilized in vitro assays to assess M1 PAM activity and CNS penetration potential.

Main Results:

• Identified fused aromatic compounds, exemplified by naphthalene derivatives, as highly potent M1 PAMs.
• Demonstrated that these fused aromatics effectively replace the phenyl B-ring linkage.
• Achieved significant CNS penetrance with the novel scaffolds.

Conclusions:

• Fused aromatics represent a promising scaffold for developing potent and CNS-penetrant M1 PAMs.
• The findings provide a new chemical direction for M1R-targeted drug discovery.
• This research facilitates the development of novel therapeutics for CNS disorders.